Eric Myers

ERIC MYERS

Partner

Eric Myers co-founded the Grüneberg and Myers firm in 2017, to offer clients high-quality patent counsel with personalized focus and client-centric efficiency. Since the founding of the firm, he has earned listings in Thomson Reuters’ Super Lawyers Rising Stars list for three consecutive years. In this time, IAM 1000 has also lauded the firm with a prestigious listing among the world’s top IP firms.

Mr. Myers brings perspective from the offices of decision-makers in highly contentious proceedings. He spent a year working under the Honorable Paul J. Luckern, the longest-serving Administrative Law Judge in the history of the International Trade Commission (ITC). Under the guidance of Judge Luckern, Mr. Myers handled responsibilities at the ITC including drafting claim construction, infringement, and validity findings for 337 investigations into importation of alleged infringing goods. These experiences set the foundation for Mr. Myers’s commitment to high standards of quality in prosecution and counseling.

Mr. Myers counsels clients on a wide variety of patent issues including patentability, invalidity, noninfringement, design-around strategies, and challenging patent validity after issuance. In addition to patent prosecution, he opines on patents, portfolios, and landscapes in various contexts including pending acquisitions and potentially adversarial circumstances.

Companies across the globe, including many in North America, Europe, and Asia, have relied on Mr. Myers to carefully and timely evaluate various patent concerns. Appreciating that intellectual property issues can greatly impact clients’ business, Mr. Myers seeks to provide well-supported and clear analysis to guide clients’ decisions and obtain favorable outcomes.

Having studied developments in the patent and regulatory laws governing pioneer and generic pharmaceuticals, Mr. Myers provides counsel on issues unique to pharmaceutical intellectual property. His experience extends to matters of patent term extension, Orange Book listings, and IP-related aspects of FDA submissions.

Major multinational corporations, startup companies, and academic institutions alike trust Mr. Myers to obtain strong patent coverage from their applications before the U.S. Patent and Trademark Office (USPTO). Mr. Myers prosecutes patent applications in a wide range of technologies including biotechnology, pharmaceuticals, coatings, adhesives, cosmetics, hygiene products, foods, nutritional products, glass products, inks, toners, alloys, smart manufacturing, plastics and polymers, organic synthesis methods, petrochemicals, fuel additives, packaging materials, semiconductors, light-emitting materials, and textiles. Mr. Myers handles all stages of prosecution, frequently discussing matters with USPTO examiners and staff to efficiently resolve issues in clients’ applications. Mr. Myers also advocates before the Patent Trial and Appeal Board both in briefs and in oral hearings. In other exceptional cases in clients’ applications, Mr. Myers has been effective in filing petitions to the Director of the USPTO.

Prior to his career in patent law, Mr. Myers researched metal oxide nanoparticle synthesis and catalysis, culminating in an honors thesis as a member of the Schreyer Honors College at Penn State. Mr. Myers also investigated carbon nanotube applications in atomic force microscopy at the New Jersey Institute of Technology with support from the National Science Foundation.